China Biologic Products EBITDA margin

What is the EBITDA margin of China Biologic Products?

The EBITDA margin of China Biologic Products Holdings, Inc. is 42.45%

What is the definition of EBITDA margin?

EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.

ttm (trailing twelve months)

EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.

EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.

EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.

EBITDA margin of companies in the Miscellaneous sector on LSE compared to China Biologic Products

Companies with ebitda margin similar to China Biologic Products

Legacy Housing has EBITDA margin of 42.33%
Amerigo Resources has EBITDA margin of 42.34%
ACNB has EBITDA margin of 42.36%
Pharos plc has EBITDA margin of 42.37%
Lilis has EBITDA margin of 42.40%
Silvercorp Metals has EBITDA margin of 42.44%
China Biologic Products has EBITDA margin of 42.45%
United Overseas Bank (Singapore) has EBITDA margin of 42.46%
First Bancshares Inc Miss has EBITDA margin of 42.50%
WEC Inc has EBITDA margin of 42.51%
National Grid Plc has EBITDA margin of 42.51%
PetroShale has EBITDA margin of 42.52%
Divi's Laboratories has EBITDA margin of 42.52%